AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline
Keyword: Immunology
April 29 (Reuters) - AbbVie on Wednesday reported better-than-expected quarterly revenue and profit, fueled by demand for newer immunology drugs Skyrizi and Rinvoq, as the drugmaker continues to navi… [+1817 chars]
Read Full Story ↗
Related Content
-
Related Story BBC Inside Science
SaaS Metrics